It looks like your browser is not up to date.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Adamis Pharmaceuticals Corp (ADMP) USD0.0001

Sell:$0.75 Buy:$0.76 Change: $0.0103 (1.36%)
Market closed |  Prices as at close on 18 May 2021 | Switch to live prices |
Sell:$0.75
Buy:$0.76
Change: $0.0103 (1.36%)
Market closed |  Prices as at close on 18 May 2021 | Switch to live prices |
Sell:$0.75
Buy:$0.76
Change: $0.0103 (1.36%)
Market closed |  Prices as at close on 18 May 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company's product portfolio includes specialty pharmaceutical products, such as Epinephrine pre-filled syringe (PFS), APC-5000 dry powder inhaler (DPI), APC-1000 and APC-2000, and biotechnology products, such as TeloB-VAX (vaccine), APC-100, APC-200 and APC-300. The Company's lead product candidate, the Epinephrine Injection USP 1:1000 0.3 milligram Pre-filled Single Dose Syringe, or the Epinephrine PFS, is a pre-filled syringe designed to deliver a premeasured 0.3 milligrams dose of epinephrine for the treatment of anaphylaxis. The Company also has licensed vaccine technology called somatic transgene immunization (STI) technology.

Contact details

Address:
11682 El Camino Real Ste 300
SAN DIEGO
92130-2092
United States
Telephone:
+1 (858) 9972400
Website:
www.adamispharmaceuticals.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ADMP
ISIN:
US00547W2089
Market cap:
$105.60 million
Shares in issue:
148.89 million
Sector:
Pharmaceuticals
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Richard Williams
    Independent Chairman of the Board, Consultant
  • Dennis Carlo
    President, Chief Executive Officer, Director
  • Robert Hopkins
    Chief Financial Officer, Senior Vice President - Finance
  • David Marguglio
    Senior Vice President, Chief Business Officer and Director
  • Karen Daniels
    Vice President - Operations
  • Ronald Moss
    Chief Medical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.